People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Novocell, Inc | — | Biotechnology | Pre-Seed | $304K | $16.8M | 2010 |
Anne J. Sandan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anne J. Sandan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Fred A. Middleton | 1 | 9 |
| Orville G. Kolterman | 1 | 3 |
| Donald J Elmer | 1 | 3 |
| Franklin P. Johnson | 1 | 2 |
| Liz G. Bui | 1 | 2 |
| Allan H. Robins | 1 | 1 |
| E. Edward Baete | 1 | 1 |
| Niamh G. Pellegrini | 1 | 1 |
| Anne G. Bang | 1 | 1 |
| Mitchell H. Finer | 1 | 1 |
| John S. West | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.